Home  |  Contact

UniProtKB/Swiss-Prot P15529: Variant p.Cys35Tyr

Membrane cofactor protein
Gene: CD46
Variant information

Variant position:  35
The position of the amino-acid change on the UniProtKB canonical protein sequence.

Type of variant:  LP/P [Disclaimer]
The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance

Residue change:  From Cysteine (C) to Tyrosine (Y) at position 35 (C35Y, p.Cys35Tyr).
Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.

Physico-chemical properties:  Change from medium size and polar (C) to large size and aromatic (Y)
The physico-chemical property of the reference and variant residues and the change implicated.

BLOSUM score:  -2
The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page

Variant description:  In AHUS2.
Any additional useful information about the variant.

Other resources:  
Links to websites of interest for the variant.



Sequence information

Variant position:  35
The position of the amino-acid change on the UniProtKB canonical protein sequence.

Protein sequence length:  392
The length of the canonical sequence.

Location on the sequence:   RFPGLLLAAMVLLLYSFSDA  C EEPPTFEAMELIGKPKPYYE
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.

Sequence annotation in neighborhood:  
The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.

TypePositionsDescription
Chain 35 – 392 Membrane cofactor protein
Topological domain 35 – 343 Extracellular
Domain 35 – 96 Sushi 1
Disulfide bond 35 – 80
Alternative sequence 33 – 33 D -> G. In isoform 3.
Alternative sequence 34 – 96 Missing. In isoform 3.


Literature citations

Membrane cofactor protein (MCP; CD46): isoform-specific tyrosine phosphorylation.
Wang G.; Liszewski M.K.; Chan A.C.; Atkinson J.P.;
J. Immunol. 164:1839-1846(2000)
Cited for: PHOSPHORYLATION AT TYR-384 (ISOFORM B); PHOSPHORYLATION AT TYR-369 (ISOFORM D); PHOSPHORYLATION AT TYR-354 (ISOFORM F); PHOSPHORYLATION AT TYR-370 (ISOFORM H); PHOSPHORYLATION AT TYR-355 (ISOFORM J); PHOSPHORYLATION AT TYR-340 (ISOFORM L); PHOSPHORYLATION AT TYR-321 (ISOFORM 3);

Genetics of HUS: the impact of MCP, CFH, and IF mutations on clinical presentation, response to treatment, and outcome.
Caprioli J.; Noris M.; Brioschi S.; Pianetti G.; Castelletti F.; Bettinaglio P.; Mele C.; Bresin E.; Cassis L.; Gamba S.; Porrati F.; Bucchioni S.; Monteferrante G.; Fang C.J.; Liszewski M.K.; Kavanagh D.; Atkinson J.P.; Remuzzi G.;
Blood 108:1267-1279(2006)
Cited for: VARIANT AHUS2 TYR-35;

Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.